Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Matthew Salzmann elected as new BGMA Vice Chair

Matthew Salzmann elected as new BGMA Vice Chair

He is committed to making the UK a global hub for off-patent medicine innovation 

The British Generic Manufacturers Association (BGMA) has elected Matthew Salzmann, UK Country Manager at Viatris, as its new Vice-Chair with immediate effect.


He will replace the current chair of the BGMA, Diane DiGangi-Trench, who is the UK country head for Sandoz.

Salzman, who is originally from Australia, has served approximately 1 billion patients worldwide last year as the UK Country Manager at Viatris, a global pharmaceutical company operating in 165 countries.

In his role as BGMA Vice-Chair, Salzmann would focus on working in partnership with key stakeholders – the NHS, healthcare professionals, policy makers, clinical societies, patient associations, academia - to ensure access to affordable and sustainable medicines for patients and the NHS.

Salzmann said: “I would like us to contribute at making the UK a globally attractive environment for companies to invest in and launch off-patent medicines. Swift licensing processes and streamlined NHS stock allocations are essential components of this goal.”

Screenshot 2023 12 07 004235

The BGMA members supply approximately 85 per cent of NHS medicines, saving the system around £15 billion annually.

Currently, the association is following closely the operationalisation of the recently announced Voluntary scheme for branded medicines, pricing, access and growth (VPAG).

Mark Samuels, chief executive of the BGMA, commented that they are “very fortunate” to have someone of Salzmann’s caliber take up this position, and that they are looking forward to “even more of his input via this leadership role” into the issues that matter the most to the industry.

Matthew Salzmann elected as new BGMA Vice Chair

BGMA is the representative trade association for off-patent medicines, and its members include eight of the ten largest medicine suppliers to the NHS.

More For You

A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less
Patients to get test results via NHS app

An investment of £50m has been made to upgrade the NHS app

Patients to get test results via NHS app

Millions of patients will now be able to access test results and get appointment reminders on their smartphones as the government tries to position the NHS app as the default mode of communication and steer away from traditional methods like letters.

An investment of £50m has been made to upgrade the NHS app and the health service hopes to save £200m over the next three years.

Keep ReadingShow less
Health minister assures House of Lords on measures to tackle UK-wide Creon drug shortage

Baroness Merron

Government taking steps to mitigate shortage of cancer drug Creon

Baroness Merron on Monday (9) assured the House of Lords that the government is taking measures to mitigate the shortage of pancreatic cancer drug Creon across the country.

Raising the issue, Baroness Margaret Ritchie wanted to know about the steps being taken by the government to ease the misery of patients suffering from pancreatic cancer.

Keep ReadingShow less
Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Janet Morrison

Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Community Pharmacy England (CPE) chief executive Janet Morrison has welcomed chancellor Rachel Reeves announcement today that day-to-day spending on the NHS will increase by £29bn a year but insisted that it must reflect in securing the future of pharmacy.

Reeves also revealed that the government will be increasing the NHS technology budget by almost 50 per cent, with £10bn of investment to "bring our analogue health system into the digital age, including through the NHS app".

Keep ReadingShow less
Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less